Ten translational medical research projects joining hospital research units, universities and businesses will share €74.5 million as part of France's PIA investment scheme.
On average, six public research units and three companies were involved in each winning bid, the government said in a statement on 27 July. The 10 winners were chosen from 52 applications.
A project led by the Institut Gustave Roussy cancer research centre just south of Paris won the most funding, netting €9.3m. The project, called MyProbe, will work on breast cancer diagnostics aimed at determining which patients are at highest risk of relapse after initially successful treatment.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.